Nikolaus Virgolini

Nikolaus Virgolini

Auto-generated profile, based on publicly available information

Nikolaus Virgolini

Department of Biotechnology and Food Science CD Laboratory of Knowledge‐Based Production of Gene Therapy Vectors, Institute of Bioprocess Science and Engineering, BOKU University, Muthgasse Vienna Austria

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2020 in Biotechnology and Bioengineering
Verified
Journal Article
Open access
PDF file
MWMarcus Weinguny
Marcus Weinguny
PEPeter Eisenhut
Peter Eisenhut
GKGerald Klanert
Gerald Klanert
NVNikolaus Virgolini
Nikolaus Virgolini
NMNicolas Marx
Nicolas Marx
NBNicole Borth
Nicole Borth
Chinese hamster ovary (CHO) cells produce a large share of today's biopharmaceuticals. Still, the generation of satisfactory producer cell lines is a tedious undertaking. Recently, it was found that CHO cells, when exposed to new environmental conditions, modify their epigenome, suggesting that cells adapt their gene expression pattern to handle new challenges. The major aim of the present study was to employ artificially induced, random changes in the DNA‐methylation pattern of CHO cells to diversify cell populations and consequently increase the finding of cell lines with improved cellular characteristics. To achieve this, DNA methyltransferases and/or the ten‐eleven translocation enzymes were downregulated by RNA interference over a time span of ∼16 days. Methylation analysis of the resulting cell pools revealed that the knockdown of DNA methyltransferases was highly effective in randomly demethylating the genome. The same approach, when applied to stable CHO producer cells resulted in (a) an increased productivity diversity in the cell population, and (b) a higher number of outliers within the population, which resulted in higher specific productivity and titer in the sorted cells. These findings suggest that epigenetics play a previously underestimated, but actually important role in defining the overall cellular behavior of production clones.

7 April 2023 in Biotechnology and Bioengineering
Verified
Journal Article
Open access
NVNikolaus Virgolini
Nikolaus Virgolini
MSMarco Silvano
Marco Silvano
RHRyan Hagan
Ryan Hagan
RCRicardo Correia
Ricardo Correia
PAPaula M. Alves
Paula M. Alves
IIInes A. Isidro
Ines A. Isidro
The insect cell‐baculovirus expression vector system (IC‐BEVS) has shown to be a powerful platform to produce complex biopharmaceutical products, such as recombinant proteins and virus‐like particles. More recently, IC‐BEVS has also been used as an alternative to produce recombinant adeno‐associated virus (rAAV). However, little is known about the variability of insect cell populations and the potential effect of heterogeneity (e.g., stochastic infection process and differences in infection kinetics) on product titer and/or quality. In this study, transcriptomics analysis of Sf9 insect cells during the production of rAAV of serotype 2 (rAAV2) using a low multiplicity of infection, dual‐baculovirus system was performed via single‐cell RNA‐sequencing (scRNA‐seq). Before infection, the principal source of variability in Sf9 insect cells was associated with the cell cycle. Over the course of infection, an increase in transcriptional heterogeneity was detected, which was linked to the expression of baculovirus genes as well as to differences in rAAV transgenes (rep, cap and gfp) expression. Noteworthy, at 24 h post‐infection, only 29.4% of cells enclosed all three necessary rAAV transgenes to produce packed rAAV2 particles, indicating limitations of the dual‐baculovirus system. In addition, the trajectory analysis herein performed highlighted that biological processes such as protein folding, metabolic processes, translation, and stress response have been significantly altered upon infection. Overall, this work reports the first application of scRNA‐seq to the IC‐BEVS and highlights significant variations in individual cells within the population, providing insight into the rational cell and process engineering toward improved rAAV2 production in IC‐BEVS.

12 October 2022 in Viruses
Verified
Journal Article
Open access
PDF file
MSMarco Silvano
Marco Silvano
RCRicardo Correia
Ricardo Correia
NVNikolaus Virgolini
Nikolaus Virgolini
CCColin Clarke
Colin Clarke
PAPaula M Alves
Paula M Alves
ARAntónio Roldão
António Roldão
Adaptive laboratory evolution has been used to improve production of influenza hemagglutinin (HA)-displaying virus-like particles (VLPs) in insect cells. However, little is known about the underlying biological mechanisms promoting higher HA-VLP expression in such adapted cell lines. In this article, we present a study of gene expression patterns associated with high-producer insect High Five cells adapted to neutral pH, in comparison to non-adapted cells, during expression of influenza HA-VLPs. RNA-seq shows a decrease in the amount of reads mapping to host cell genomes along infection, and an increase in those mapping to baculovirus and transgenes. A total of 1742 host cell genes were found differentially expressed between adapted and non-adapted cells throughout infection, 474 of those being either up- or down-regulated at both time points evaluated (12 and 24 h post-infection). Interestingly, while host cell genes were found up- and down-regulated in an approximately 1:1 ratio, all differentially expressed baculovirus genes were found to be down-regulated in infected adapted cells. Pathway analysis of differentially expressed genes revealed enrichment of ribosome biosynthesis and carbohydrate, amino acid, and lipid metabolism. In addition, oxidative phosphorylation and protein folding, sorting and degradation pathways were also found to be overrepresented. These findings contribute to our knowledge of biological mechanisms of insect cells during baculovirus-mediated transient expression and will assist the identification of potential engineering targets to increase recombinant protein production in the future.

28 May 2025 in Journal of Chemical Technology & Biotechnology
Verified
Journal Article
Open access
SLSabrina Leigheb
Sabrina Leigheb
MRMaral Rahimzadeh
Maral Rahimzadeh
NVNikolaus Virgolini
Nikolaus Virgolini
ATAida Tleuova
Aida Tleuova
MMMahbod Mousavian
Mahbod Mousavian
Patricia Pereira AguilarPatricia Pereira Aguilar
Patricia Pereira Aguilar
BACKGROUND: Adeno‐Associated Virus vectors are widely used in gene therapy due to their safety and efficacy. Despite the interest in their therapeutical application, AAV purification remains a significant challenge. Density gradient ultracentrifugation using cesium chloride, sucrose, or iodixanol gradients are common methods for AAV purification and polishing. However, when conventional ultracentrifuges are used, density gradient ultracentrifugation is not scalable and time‐consuming. To overcome these limitations, this study applies density gradient ultracentrifugation using a continuous flow ultracentrifuge which allows the development of scalable and robust AAV purification methods. RESULTS: Our results showed that continuous flow ultracentrifugation with both iodixanol and sucrose density gradients is a suitable method for AAV capture. Sucrose density gradient allowed for the recovery of 72% full AAV particles, however, poor resolution of full and empty AAV particles and co‐purification of host cell derived impurities were observed. Iodixanol density gradient allowed for the recovery of 68% full AAV particles as well as enrichment of full AAV particles in the higher density fractions. Moreover, separation of AAV particles from host cell derived impurities was achieved with the iodixanol density gradient. Nevertheless, chromatin fragments were still present. CONCLUSIONS: The findings of this study highlight the possibility of development of scalable AAV capture methods based on density gradient ultracentrifugation using continuous flow ultracentrifuges. © 2025 The Author(s). Journal of Chemical Technology and Biotechnology published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry (SCI).

9 July 2026 in Biotechnology Journal
Verified
Journal Article
Open access
GSGeorg Smesnik
Georg Smesnik
NVNikolaus Virgolini
Nikolaus Virgolini
Astrid DürauerAstrid Dürauer
Astrid Dürauer
NBNicole Borth
Nicole Borth
Recombinant adeno‐associated virus (rAAV) vectors have become the leading platform for in vivo gene delivery, yet their industrial‐scale production remains inefficient and costly. Current manufacturing, which primarily relies on transient triple‐plasmid transfection in HEK293‐derived cells, is limited by low vector yields, high empty‐to‐full capsid ratios, and pronounced batch‐to‐batch variability. To contribute to the understanding of underlying host factors, we compared transcriptomic profiles of five HEK293‐derived producer lines with varying rAAV yields over a 72‐hour production time course. The low‐producing BalCD line showed poor transfection efficiency, reduced plasmid‐derived transcript levels, exclusive interferon expression and a rapid activation of interferon‐stimulated genes (ISG), indicating strong antiviral restriction for vector productivity. In contrast, high‐producing lines mounted a reduced inflammatory and innate immune response with limited induction of antiviral genes, supporting sustained vector production. Expression patterns of high‐producing cell lines further exhibited transcriptional signatures resembling those seen for producer cells arrested in the G0/G1 cell cycle phase, which potentially favors efficient vector genome replication and capsid assembly. The observed differences in the regulation of antiviral and cell cycle–associated pathways highlight key molecular determinants of rAAV productivity and provide a foundation for targeted host engineering strategies aimed at enhancing rAAV manufacturing efficiency.

16 December 2022
Verified
Preprint
Open access
NVNikolaus Virgolini
Nikolaus Virgolini
MSMarco Silvano
Marco Silvano
RHRyan Hagan
Ryan Hagan
RCRicardo Correia
Ricardo Correia
PAPaula Alves
Paula Alves
IIInes A. Isidro
Ines A. Isidro
The insect cell-baculovirus expression vector system (IC-BEVS) has shown to be a powerful platform to produce complex biopharmaceutical products, such as recombinant proteins and VLPs. More recently IC-BEVS has been also used as an alternative to produce adeno-associated virus (AAV). However, little is known about the variability of insect cell populations and the potential effect of heterogeneity on product titer and/or quality. In this study, transcriptomics analysis of Sf9 insect cells during the production of recombinant AAV using a low multiplicity of infection, dual-baculovirus system was performed via single-cell RNA-seq (scRNA-seq). Before infection, the principal source of variability in Sf9 insect cells was associated to cell cycle. Over the course of infection, an increase in transcriptional heterogeneity was detected, this being linked to the expression of baculovirus genes as well as to differences in AAV transgenes ( rep , cap and gfp ) expression. Noteworthy, at 24 hours post-infection (hpi) only 29 % of cells showed to enclose all three necessary AAV transgenes to produce packed AAV particles, indicating limitations of the dual baculovirus system. In addition, the trajectory analysis herein performed highlighted biological processes such as protein folding, metabolic processes, translation and stress response has been significantly altered upon infection. Overall, this work reports the first application of scRNA-seq to the IC-BEVS and highlights significant variations in individual cells within the population, providing insight for rational cell and process engineering towards improved AAV production in IC-BEVS.